(Q44479268)

English

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study (English)

1 reference

Europe PubMed Central

3 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Evangelos Rizos

1

1 reference

Europe PubMed Central

3 December 2017

Eleni Bairaktari

2

1 reference

Europe PubMed Central

3 December 2017

Angeliki Kostoula

3

1 reference

Europe PubMed Central

3 December 2017

George Hasiotis

4

1 reference

Europe PubMed Central

3 December 2017

Apostolos Achimastos

5

1 reference

Europe PubMed Central

3 December 2017

Emanuel Ganotakis

6

1 reference

Europe PubMed Central

3 December 2017

Moses Elisaf

7

1 reference

Europe PubMed Central

3 December 2017

D P Mikhailidis

8

1 reference

Europe PubMed Central

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

3 December 2017

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

3 December 2017

8

1 reference

Europe PubMed Central

3 December 2017

2

1 reference

Europe PubMed Central

3 December 2017

127-134

1 reference

Europe PubMed Central

3 December 2017

Nebivolol in the management of essential hypertension: a review

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Clinical significance of pleiotropic effects of statins: lipid reduction and beyond

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Homocysteine, adrenergic activity and left ventricular mass in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Antihypertensive and Metabolic Effects of Single and Combined Atenolol Regimens

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

A dose-response study of atenolol in mild to moderate hypertension in general practice

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives.

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Comparative study of HMG-CoA reductase inhibitors on fibrinogen

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Do HMG-CoA reductase inhibitors affect fibrinogen?

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Effect of atorvastatin on serum uric acid levels

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT).

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800206

21 January 2018

Identifiers

10.1177/107424840300800206

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44479268&oldid=2025290251"